Cargando…
Thyroid hormone replacement one day before (131)I therapy in patients with well-differentiated thyroid cancer
OBJECTIVE: The current study aimed to determine the efficacy of radioiodine-131 ((131)I) ablation therapy with thyroid hormone replacement one day before (131)I administration in patients with well-differentiated thyroid cancer (DTC). METHODS: This retrospective study included 29 patients who underw...
Autores principales: | Kayano, Daiki, Taki, Junichi, Inaki, Anri, Wakabayashi, Hiroshi, Nakamura, Ayane, Fukuoka, Makoto, Kinuya, Seigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Oceania Journal of Nuclear Medicine & Biology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937667/ https://www.ncbi.nlm.nih.gov/pubmed/27408838 http://dx.doi.org/10.7508/aojnmb.2013.01.005 |
Ejemplares similares
-
Extremity Radioactive Iodine Uptake on Post-therapeutic Whole Body Scan in Patients with Differentiated Thyroid Cancer
por: Wakabayashi, Hiroshi, et al.
Publicado: (2015) -
Prognostic values of initial responses to low-dose (131)I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
por: Wakabayashi, Hiroshi, et al.
Publicado: (2013) -
I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma
por: Sato, Yuya, et al.
Publicado: (2012) -
Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during (131)I-meta-iodo-benzyl-guanidine therapy
por: Taniguchi, Yuka, et al.
Publicado: (2022) -
Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
por: Kayano, Daiki, et al.
Publicado: (2015)